Sort   by:  
 Page size 
Viruses must effectively remodel host cellular pathways to replicate and evade immune defenses, and they must do so with limited genomic coding capacity. Targeting post-translational modification (PTM) pathways provides a mechanism by which viruses can broadly and rapidly transform a hostile host en...
ORGANISM(S): Homo sapiens (Human) 
2022-04-14 | PXD032085 | Pride
Background: Since its emergence in 2020, circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been dominated by waves of genetically distinct variants with varying pathogenicity. Understanding the molecular mechanisms underlying SARS-CoV-2 pathogenesis, and the host and viral...
ORGANISM(S): Mesocricetus auratus (Golden hamster) 
2026-01-26 | PXD054808 | Pride
In humans, lymph nodes are the primary site of measles virus (MeV) replication. To understand the immunological events that occur at this site, we infected human lymphoid tissue explants using a pathogenic strain of MeV that expresses GFP. We found that MeV infected between 5-15% of cells across don...
ORGANISM(S): Homo sapiens (Human) 
2024-09-10 | PXD054861 | Pride
The development of a prophylactic vaccine for Kaposi sarcoma-associated Herpesvirus (KSHV) would prevent consequences from infection including disorders such as Kaposi sarcoma and primary effusion lymphoma. Here, we study the immunogenicity of noninfectious virus-like vesicles (VLVs) of KSHV as a po...
ORGANISM(S): Homo sapiens (Human) Human gammaherpesvirus 8 
2023-02-01 | PXD035478 | Pride
The COVID-19 pandemic, caused by SARS-CoV-2, has underscored the urgency of understanding viral entry mechanisms to develop effective therapeutic strategies. SARS-CoV-2 primarily exploits angiotensin-converting enzyme 2 (ACE2) as its entry receptor and relies on the serine protease TMPRSS2 to prime ...
ORGANISM(S): Homo sapiens (Human) 
2026-03-11 | PXD075507 | Pride
The COVID-19 pandemic, caused by SARS-CoV-2, has underscored the urgency of understanding viral entry mechanisms to develop effective therapeutic strategies. SARS-CoV-2 primarily exploits angiotensin-converting enzyme 2 (ACE2) as its entry receptor and relies on the serine protease TMPRSS2 to prime ...
ORGANISM(S): Homo sapiens (Human) 
2026-03-25 | PXD075505 | Pride
Persistent HIV reservoirs in CD4⁺ T-cells impede efforts to cure HIV infection. We identified overexpression of enhancer of zeste homolog 2 (EZH2) in HIV-infected CD4⁺ T-cells that survive cytotoxic T lymphocyte (CTL) exposure, suggesting a mechanism of CTL resistance. Inhibition of EZH2 with the FD...
ORGANISM(S): Homo sapiens (Human) 
2026-01-26 | PXD061146 | Pride
Influenza B virus (IBV) strains are one of the components of seasonal influenza vaccines in both trivalent and quadrivalent formulations. The vast majority of these vaccines are produced in embryonated chickens' eggs. While optimized backbones for vaccine production in eggs exist and are in use for ...
ORGANISM(S): Influenza A virus (A/Florida/2e/2006(H3N2)) Influenza B virus (B/Hawaii/10/2001) Influenza C virus (C/Great Lakes/1167/1954) Influenza C virus 
2023-03-10 | PXD036269 | Pride
Sort   by:  
 Page size